Skip Navigation



ToxSci Advance Access published online on December 29, 2004
Toxicological Sciences, doi:10.1093/toxsci/kfi070
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow Supplementary Data - color figures
Right arrow All Versions of this Article:
84/2/214    most recent
kfi070v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Saghir, S. A.
Right arrow Articles by Schultz, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saghir, S. A.
Right arrow Articles by Schultz, I. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences © Society of Toxicology 2004; all rights reserved.
Received August 24, 2004
Accepted December 22, 2004

Biotransformation and Toxicokinetics

Toxicokinetics and Oral Bioavailability of Halogenated Acetic Acids Mixtures in Naïve and GSTzeta Depleted Rats

Shakil A. Saghir 1 and Irvin R. Schultz 1*

1 Battelle Pacific Northwest National Laboratory, Richland, Washington 99352

* To whom correspondence should be addressed.
Irvin R. Schultz, E-mail: ir_schultz{at}pnl.gov


  Abstract

Disinfection of drinking water typically produces a mixture of mono- di- and tri-halogenated acetic acids (HAAs). In this study, we investigated the toxicokinetics of HAA mixtures in naïve and GSTzeta depleted male F344 rats administered orally or i.v. to Mixture-1 (monobromo [MBAA]- dichloro- [DCAA], chlorodibromo- [CDBAA], tribromo- [TBAA] acetic acids) or Mixture-2 (bromochloro- [BCAA], dibromo- [DBAA], trichloro- [TCAA] bromodichloro- [BDCAA] acetic acids) at a dose of 25 µmol/kg HAA. Serial blood samples were collected at various times up to 36 h and the plasma concentrations of each HAA quantified by GC-ECD. Rats were pretreated for 7 d with drinking water containing 0.2 g/L DCAA to deplete the GSTzeta (GSTZ1-1) activity in the liver. An additional group of GSTzeta depleted rats were orally dosed with each mixture and euthanized at 0.25, 0.5, 1, 2 and 4 h to determine tissue distribution of mixture components. In both mixtures, GSTzeta depletion primarily affected the toxicokinetics of di-HAAs (DCAA, BCAA and DBAA) with the total body clearance (Clb) decreasing 3-10 fold. Interestingly, DCAA pretreatment appeared to increase the elimination of mixture-2 tri-HAAs (TCAA and BDCAA). After oral administration, DCAA exhibited a complex time-course plasma profile with secondary peaks appearing long after completion of the initial absorption phase. This phenomenon coincided with elevated DCA levels in the lower portion of the GI tract compared to CDBAA and TBAA. Comparison of the results with previous studies employing similar or higher doses of individual HAAs indicated the primary difference in HAA toxicokinetics when administered as mixture was a reduction in Clb. These results suggest competitive interactions between tri- and di-HAAs beyond what would be predicted from individual HAA studies. For di-HAAs, the total dose is important as clearance is dose dependent due to competition for GSTzeta. When considering HAAs dosimetry, importance should be placed on both the components of the mixture and prior exposure history to di-HAAs.

Keywords: Drinking water disinfection byproducts; halogenated acetic acids; bromo; chloro; bromochloro; chlorobromo acetic acids; oral bioavailability; toxicokinetics; pharmacokinetics; human risk assessment.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Clin PharmacolHome page
M. Jia, B. Coats, M. Chadha, B. Frentzen, J. Perez-Rodriguez, P. A. Chadik, R. A. Yost, G. N. Henderson, and P. W. Stacpoole
Human Kinetics of Orally and Intravenously Administered Low-Dose 1,2-13C-Dichloroacetate.
J. Clin. Pharmacol., December 1, 2006; 46(12): 1449 - 1459.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
I. R. Schultz and R. E. Shangraw
Effect of Short-Term Drinking Water Exposure to Dichloroacetate on its Pharmacokinetics and Oral Bioavailability in Human Volunteers: A Stable Isotope Study
Toxicol. Sci., July 1, 2006; 92(1): 42 - 50.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.